Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSA-Scale validation in Alzheimer's disease patients treated with Axura
2008-005144-16Phase 3Completed
- Sponsor
- Merz
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of memantine in Alzheimer's disease (AD), sponsored by Merz. Primary endpoint: ROSA-Scale validation. Started Oct 2008; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2008-005144-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005144-16.